Novo Nordisk A/S Sponsored ADR Class B (NVO) is currently at $37.74, down $0.42 or 1.11%
--Would be lowest close since May 6, 2021, when it closed at $37.10
--On pace for largest percent decrease since Feb. 25, 2026, when it fell 1.11%
--Currently down eight consecutive days; down 23.88% over this period
--Longest losing streak since Nov. 4, 2025, when it fell for 11 straight trading days
--Worst eight day stretch since the eight days ending Feb. 6, 2026, when it fell 24.25%
--Down 36.51% month-to-date; on pace for worst month on record (Based on available data back to April 30, 1981)
--Down 25.84% year-to-date
--Down 74.31% from its all-time closing high of $146.91 on June 25, 2024
--Down 57.71% from 52 weeks ago (Feb. 27, 2025), when it closed at $89.22
--Down 58.47% from its 52-week closing high of $90.86 on March 5, 2025
--Would be a new 52-week closing low
--Traded as low as $37.33; lowest intraday level since May 6, 2021, when it hit $36.76
--Down 2.18% at today's intraday low
All data as of 11:38:31 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 26, 2026 11:42 ET (16:42 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.